MP CM in Spain on official tour
He will address the 'Invest in Madhya Pradesh Business Forum' in Madrid and participate in high-level meetings related to industry, tourism, sports, culture and film production.
Day one will begin with a courtesy call by India's Ambassador to Spain, Dinesh K Patnaik, followed by the Chief Minister's participation as chief guest in the Forum. During the session, senior officials will give presentations on tourism, industrial policy and investment, information technology and infrastructure sectors.
The Forum will commence with a welcome address by Ilayaraja T, Secretary to the Government of Madhya Pradesh and Secretary to the Chief Minister. The President of the Spain-India Council Foundation, Juan Ignacio Entrecanales, will also address the Forum. Rohan Grover, Chief Executive Officer of Nature Biofoods, shall share his experiences.
Yadav will provide detailed insights to participating industrialists about investment opportunities across various sectors in Madhya Pradesh. During the networking lunch, he shall interact with prominent Spanish industrialists and representatives of different organisations.
The Chief Minister will also attend a presentation by the renowned sports infrastructure design and consulting firm Populous, delivered by Jorge Betancourt. The session shall focus on the development of modern sports infrastructure in Madhya Pradesh.
Later, the President of the Spain Film Commission will meet with the Chief Minister to discuss international-level film shooting and collaboration opportunities in Madhya Pradesh. Yadav will also visit the world-famous Prado Museum.
He shall interact with representatives of the Indian business community based in Spain and attend a special dinner event in Madrid.
UNI AC RKM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
21 minutes ago
- Economic Times
US' new tariff list: India at 25%, exports to get hit, competitors in lower band
Synopsis Effective August 7, 2025, the US has imposed a blanket 25% tariff on all Indian-origin goods, placing India among the most harshly treated nations in its new tariff regime. This measure, part of a new Executive Order, denies India product-level exemptions, even for critical sectors like pharmaceuticals and electronics. Agencies US' new tariff list New Delhi: In a move that could dent India's exports to US, Washington has imposed a blanket 25% tariff on all Indian-origin goods, effective August 7, measure, part of a new Executive Order issued by US President Donald Trump on July 31, places India among the most harshly treated countries in the new American tariff regime, offering no product-level exemptions even for sectors deemed critical like pharmaceuticals, energy, and Order mentions that tariffs may be reduced once countries do a deal with the per the order, countries have been subject to tariffs ranging from 10% to over 41% with differential rates based on geopolitical risk, economic alignment, and trade said the new order puts India at disadvantage to majority competitors including Pakistan, Vietnam, Bangladesh, Turkey where the tariffs are 15-20%. 'India's exports of petroleum products, smartphones, pharmaceuticals, engineering goods, electronics, and textiles will bear the brunt of the tariffs,' said a representative of an export promotion penalty threatened by Trump on India for doing business with Russia has not yet been US, Wednesday, announced 25% tariffs on India along with undisclosed penalty on trading with Russia.'The implications of the recent development are being examined by the government. The Ministry of Commerce and Industry is engaged with all stakeholders including exporters and industry for taking feedback of their assessment of the situation,' commerce and industry minister Piyush Goyal said in his statement in Parliament US was India's largest export destination in FY25 with shipments valued at $86.51 billion. But it accounted for less than a fifth of its total goods exports of $437.42 per the Order, unlike many other trading partners, India has been denied all product-level exemptions—even for products and sectors, the US exempted Goods from other tariff exempted categories include finished pharmaceutical drugs, APIsand other key drug inputs; energy products, critical minerals and a wide range of electronics and EU has been granted a special concession in which if the existing US most favoured nation (MFN) tariff on an EU product is below 15%, the total tariff will be increased to 15%. However, if the MFN tariff is already 15% or higher, then no additional duty will be charged.A 10% tariff applies to a few countries—Brazil, the UK, and the Falkland 15% tariff, which is the most common, covers 38 countries. Countries facing higher tariffs (25-30%) include India, Brunei, Kazakhstan, Moldova, and and Serbia at 35%, Switzerland at 39% (unusually high for a developed nation), Laos and Myanmar at 40%, and Syria at 41%, the US Customs Border Protection authority will realise a guidance clarifying on how this measure will be applied.
Economic Times
21 minutes ago
- Economic Times
Not only Bengalis, every citizen has right to go anywhere in India, says economist Amartya Sen
Wading into the political slugfest over the alleged harassment of Bengali migrant workers in other parts of the country, noted economist Amartya Sen said every citizen of India has the freedom to go wherever they want, and any effort to curb that must be objected to. Speaking to reporters at his ancestral home in Santiniketan, Sen said it doesn't matter whether a person is a Bengali, Punjabi or a Marwari, the freedom to go wherever he wants and speak whichever language he wants is his constitutional right. "An Indian citizen has the right of movement in the entire country. There is no mention of territorial rights anywhere in our Constitution," he said."Every citizen of India has the right to be happy. We have to respect everyone...," he said on Thursday, responding to a question from reporters on the issue that has rocked the state. Sen said if Bengalis are being tortured and neglected, it must be objected to. "It is not a question of Bengal alone, but the whole country," he added."The language that was integrated with 'Charyapad' (Bangla), its value must be acknowledged. Various poems have been written in that language. The messages of Rabindranath Tagore and Kazi Nazrul Islam have been laid out very clearly in their works. These values must be acknowledged," he TMC has been raising its voice over the last one month, alleging that Bengali-speaking people, especially poor Muslim migrant workers, are being harassed in BJP-ruled states and being branded illegal Bangladeshi Minister Mamata Banerjee has led a mega rally in Kolkata over the issue last month, and also started 'Bhasa Andolan', sharpening her attack on the BJP. The BJP, on the other hand, has dismissed the allegations, claiming that the TMC did not think about the welfare of migrant workers over the last 14 years, and was now raising the issue with an eye on next year's assembly elections in the state.
Hans India
23 minutes ago
- Hans India
Trump asks 17 non-Indian drug majors to cut prices in US; Nifty pharma dips
Mumbai: A letter from US President Donald Trump has asked 17 global drug giants to cut their prices in the country, sparking severe losses for them, as its impact hit the Indian stock market too. The letter urged that these businesses cut US drug pricing to match prices in other developed markets. Though no Indian pharmaceutical companies received Trump's letters, the Nifty Pharma index reacted sharply, falling 2.45 per cent during the intra-day trade on Friday. The index fell for the third day in a row. Sun Pharmaceutical Industries Ltd fell 3.98 per cent. Aurobindo Pharma lost 3.42 per cent and Granules India lost 3.2 per cent. Gland Pharma, Cipla, and Lupin fell 2 to 3 per cent. The US President wrote to 17 of the world's major pharmaceutical corporations, pressing them to lower drug prices immediately and give assurance that future drugs will be priced in line with other countries. The letters were sent to Eli Lilly, Novo Nordisk, Pfizer, and others, seeking 'Most Favoured Nation' (MFN) pricing for US within 60 days. White House Press Secretary Karoline Leavitt said recent data showed that Americans paid more than three times more for brand-name drugs than other developed nations. Trump had earlier made a similar announcement on May 12, asking pharma companies to cut prices in US. Industry sources in India had then said Trump's proposal might hurt Indian exporters of branded generics to the US, given generic drugs are already sold at low prices. If prices are cut further, it will make shipping unviable, they said. A third of Indian pharmaceutical exports of $30 billion annually, reach the US market. Trump gave drug companies 60 days to voluntarily comply with the new pricing diktat in the letter, failing which, he said, the US would use 'every tool in our arsenal' to protect Americans from 'continued abusive drug pricing' practices. Trump's letter required companies to sell certain drugs directly to patients at prices at which they are offered to third-party insurers.
